CLOs on the Move

Menlo Therapeutics

www.menlotherapeutics.com

 
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Equideum Health

Equideum Health creates Web3 person-centered healthcare and research networks to advance health equity and outcomes by optimizing data liquidity across enterprise and individual data silos, powered by Ethereum.

Mayo Clinic Health System

Mayo Clinic Health System is a system of community-based medical facilities.

Chad Therapeutics, Inc.

CHAD Therapeutics, Inc. (CHAD) was established to develop, produce and market respiratory care devices designed to improve the efficiency of oxygen delivery systems for both home and hospital treatment of patients who require supplemental oxygen.

EnovateIT

EnovateIT is a Canton, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Salud Dorada con Medicare

Salud Dorada con Medicare is a Bayamon, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.